It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release is safe for baby while breastfed.
What is Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release ?
APTENSIO XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [ see Clinical Studies (14)]. APTENSIO XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. (1) Limitations of Use: Pediatric patients younger than 6 years of age experienced higher plasma exposure than patients 6 years and older at the same dose and high rates of adverse reactions, most notably weight loss. (8.4) Limitations of Use Pediatric patients younger than 6 years of age experienced higher plasma exposure than patients 6 years and older at the same dose and high rates of adverse reactions, most notably weight loss [see Use in Specific Populations (8.4)].
Is using Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release safe or dangerous while breastfeeding?
Methylphenidate hydrochloride is the only one ingredient used in manufacturing of Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Methylphenidate hydrochloride it is safe to use Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release while lactating. We suggest you to check further details below about Methylphenidate hydrochloride usage in breastfeeding.
Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release Breastfeeding Analsys
SafeCAS Number: 113-45-1
The amount excreted to breast milk is so small that it is not detected in breast-fed infants. No adverse side-effects have been reported. Check-up for milk production since it may decrease Prolactin excretion on theoretical basis.
Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release Breastfeeding Analsys - 2
CAS Number: 113-45-1
In dosages prescribed for medical indications, limited evidence indicates that methylphenidate levels in milk are very low and not detectable in infant serum. The effects of methylphenidate in milk on the neurological development of the infant have not been well studied. If methylphenidate is required by the mother, it is not a reason to discontinue breastfeeding.[1] It is possible that large dosages of methylphenidate might interfere with milk production, especially in women whose lactation is not well established.

What should I do if already breastfed my kid after using Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release?
As usage of Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release else no further action is required.
My doctor has prescribed me Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release, what should I do?
Definitely, Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release
Who can I talk to if I have questions about usage of Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week
Drug Brands with same Active ingredients